Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study to Collect and Assess Tissue Samples From Subjects With One of Three Neoplastic Conditions (ANSWer)

NCT04014764 is registered in ClinicalTrials.gov with Notable Labs as lead sponsor.

NCT NCT04014764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04014764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study to Collect and Assess Tissue Samples From Subjects With One of Three Neoplastic Conditions (ANSWer)
Lead sponsor
Notable Labs
Phase
Observational
Overall status
Completed
Start date
December 15, 2019
Completion date
March 31, 2022
Enrollment
119 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myelogenous leukemia, chronic myelogenous leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, myeloproliferative neoplasm